THOMAS RAMOS: Open Payments
NPI 1285241042 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 43 payments from 14 companies in 2025. Trend: 2023 $444 · 2024 $678 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $182 |
| Travere Therapeutics, Inc. | 7 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| Fresenius USA Marketing, Inc. | 4 | $84 |
| Calliditas Therapeutics US Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Vifor Pharma, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lilly USA, LLC | 1 | $25 |
Products named: Kerendia, VELPHORO, Vanrafia, TARPEYO, JYNARQUE, ACTHAR, Veltassa, Fabhalta.
Industry payments across NC — which companies pay providers there.
